Ozempic Expands Its Reach: FDA Approves use for Chronic Kidney Disease in Type 2 Diabetes Patients PLAINSBORO, N.J. — In a groundbreaking move, the U.S.Food and Drug Administration (FDA) has expanded the approved uses of Ozempic, a GLP-1 drug initially approved in 2017 to treat type 2 diabetes, to now include reducing risks associated with … Read more
FDA Approves Ozempic to Reduce Risks Linked to Chronic Kidney disease in Adults with Type 2 Diabetes PLAINSBORO, N.J. — In a groundbreaking move, teh U.S. Food and Drug Administration (FDA) has expanded the approval of Ozempic, the widely recognized GLP-1 drug, to include reducing risks associated with chronic kidney disease (CKD) in adults with … Read more
“`html High Cost of Weight-Loss Drugs Raises Concerns High Cost of Weight-Loss Drugs Raises Concerns The rising popularity of glucagon-like peptide-1 agonists (GLP-1s) like Wegovy (semaglutide) for weight loss has brought a new set of challenges too the forefront: surprisingly high healthcare costs. While these medications show promise in helping individuals manage obesity and even … Read more